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A bacterial cDNA clone was identified carrying one third of the nucleotides coding for elongation factor 
EF-lcu from the brine shrimp Artemia. The sequence of codons corresponds with the known sequence of 
amino acids of EF-la in the region involved. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The aminoacyl-tRNA binding enzymes of pro- 
karyotes and eukaryotes &e major cellular pro- 
teins [I ,2], which possess related primary struc- 
tures in both cell types [3-61. Much less is known 
about the structure and function of these proteins 
in eukaryotes than in prokaryotes. 
2.1. Isolation of RNA from developing Artemia 
cysts 
Like EF-Tu in Escherichia coli, EF-la! plays the 
same pivotal role in protein synthesis, but it ag- 
gregates often with other proteins, the complex be- 
ing called EF-1 [7]. In dormant cysts of the brine 
shrimp Artemiu the high M, form consists of a 
complex of 3 different polypeptide chains, EF-Ia, 
EF-lfl and EF-ly [8]. In nauplii the aminoacyl- 
tRNA binding activity is mainly found in the free 
EF-la protein chain of about 50 kDa and with an 
isoelectric point of 8.5, while the EF-lfly complex 
stimulates guanine nucleotide exchange [9]. 
To study the regulation of the elongation cycle 
of protein synthesis in eukaryotic cells, we have 
started an investigation of EF-la in Artemia. 
Here, we describe the molecular cloning in E. coli 
of an EF-1~ encoding mRNA fraction [lo] and the 
sequence analysis of an EF-la cDNA clone, carry- 
ing a 542 bp insert. 
For extraction of RNA from cysts the urea/LiCl 
procedure [l l] was adapted. Dried cysts were 
washed and developed as in [lo]. The cysts were 
ground in a mortar at 4°C in the presence of 6 M 
urea, 3 M LiCl and homogenized in a Sorvall om- 
nimixer. After filtration the suspension was diluted 
with urea, 3 M LiCl and homogenized in a Sorvall 
omnimixer. After filtration the suspension was 
diluted with urea/LiCl and stored overnight at 
-20°C. Following centrifugation (20 min at 
20000 x g) the pellet was dissolved in 10 mM 
Tris-HCl (pH 8.8), 5 mM EDTA, 1% SDS and 
the solution extracted 2 or 3 times with phenol, 
chloroform, isoamylalcohol (SO/SO/l, by vol.). 
After precipitation with ethanol, poly(A)+ RNA 
was selected and subsequently fractionated on 
sucrose gradients containing CHsHgOH [lo]. 
2.2. cDNA synthesis and molecular cloning 
Most of the methods employed are slightly 
modified versions of the procedures referred to. 
The assay of mRNA and immunoprecipitation of 
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the translation product were performed as in [lo]. 
Synthesis of cDNA, digestion with Sr-nuclease, 
DNA gel electrophoresis and the sources of, the 
various enzymes and chemicals were as in [ 121. 
Transformation of competent E. coli K12 RR1 
cells, the plating, growing of colonies, and the 
isolation of plasmid DNA have been published 
[13-151. 
2.3. Homopolymer tailing 
Double-stranded, Sr-nuclease treated cDNA was 
extended with dC tails essentially as in [16]. PstI 
restricted pAT 153 DNA; dG-tailed in the same 
way was used as a cloning vehicle. To assay the 
rate of addition of dC residues, fractions were 
diluted with an equal volume of water, inactivated 
by heating for 10 min at 65°C and restriction 
digested with Hid. Agarose gel-electrophoretic 
analysis clearly showed a ‘growing fragment’ 
(fig.1). The optimum length of the dG tails was 
determined by transformation of competent E. coli 
cells after annealing with dC-tailed plasmid DNA. 
2.4. Hybridization-released translation 
Plasmid DNA was linearized with EcoRI, 
denatured and spotted on nitrocellulose filters 
(Genescreen, NEN). For testing a large number of 
clones a Hybridot spotting device (BRL) has 
shown to be convenient. The filters were baked 
and prehybridized in 0.1 M Tris-HCl (pH 7.6), 
0.75 M NaCl, 2 mM EDTA, 0.5% SDS, 50% for- 
mamide, 6Opg/ml yeast tRNA, and 70 pg/ml 
poly(A). After 4 h at 37”C, 0.5 mg poly(A)+ RNA 
from Artemia was added and the hybridization 
was continued for 20 h at 37°C. The filters were 
washed at 20°C with 10 mM Tris-HCl (pH 7.6), 
1 mM EDTA, 100 mM NaCl (TEN), 0.2% SDS, 
with TEN and with TE, about IO-times each. 
Subsequently, the hybridized RNA was eluted by 
incubating each filter for 5 min at 80°C in 2 mM 
EDTA (pH 7.0) in an Eppendorff tube. The elu- 
tion step was repeated and after addition of yeast 
tRNA as a carrier, the nucleic acids were 
precipitated twice with ethanol and analyzed as 
above. 
2.5. Sequencing methods 
For DNA sequence determination the cDNA 
clone was digested with PstI and the insert was 
eluted by means of electrophoresis from a 
290 
preparative agarose gel. The insert was ligated in 
the PstI site of pUC8 and recloned in E. coli JM 
101 [ 171. Besides the PstI side the polylinker of this 
vector provides a SalI site suitable for 5 ’ (T4 
polynucleotide kinase) as well as 3 ’ (Klenow DNA 
polymerase) labeling and EcoRI or BamHI sites 
for the generation of single-end labeled fragments. 
The chemical modification method of Maxam and 
Gilbert [18] was employed for DNA sequencing. 
3. RESULTS AND DISCUSSION 
3.1. Molecular cloning and clone identification 
For extraction of RNA from Artemia cysts the 
urea/LiCl procedure applied turned out to be 
faster and less expensive than sedimentation 
through CsCl gradients used in [IO]. Template ac- 
tivity does not show marked differences between 
the two methods. 
Using about 1.5 pg poly(A)+ RNA fraction 
enriched in sequences coding for EF-la, we en- 
countered no special difficulties up to the stage of 
tailing and annealing. These were optimized using 
PAT 153 DNA as a model in two separate ex- 
periments. Concerning the dC tailing, the gel- 
electrophoretic assay (fig.1) shows that he addi- 
tion of dC residues proceeds linearly with time at 
about 3 residues/min. With respect o the dG tail- 
ing, PAT 153 DNA was linearized by digestion 
with PstI and divided in two portions, which were 
tailed with dG and dC residues, respectively. After 
annealing and transformation of competent E. coli 
cells the ampicillin-sensitive fraction of the 
tetracycline-resistant transformants was determin- 
ed. We concluded that 4-5 min of dC tailing and 
7-15 min of dG tailing provided satisfactory 
results. 
After annealing the dC-tailed cDNA with the 
dG-tailed vector a sample was used to transform 
Ca2+-treated E. coli RR1 cells. The efficiency of 
transformation was about 8 x 10’ colonies/pg 
PAT 153 DNA and about 50% of the obtained 
transformants were found to be sensitive to am- 
picillin. Clones carrying inserts of more than 
400 bp were used for hybrid-releasing translation. 
One of them (clone 13) showed a faint band of 
50 kDa on an SDS gel after immunoprecipitation 
with EF-FLU antibodies. Plasmid DNA from the 
clones 13 and 21 was purified by CsCl gradient 
centrifugation and the hybrid-released translation 
Volume 157, number 2 FEBS LETTERS July 1983 
time (mid 
0 2.5 5 10 15 20 40 60 0 
bp 
1387 
516 
396 
298 
246 
2211220 
1451S4 
75 
Fig.1. Homopolymer tailing. PstI-restricted PAT 153 
DNA was tailed with dC residues by means of terminal 
transferase (EC 2.7.7.31). At the times indicated samples 
were inactivated, digested with HinfI and analyzed on a 
1.5% agarose gel in the presence of ethidium bromide. 
The 1393 and 246 bp fragments are carrying the dC tails 
at one of their 3’ends. 
procedure was repeated (fig.2). Only clone 13 
shows a 50 kDa polypeptide in the protein syn- 
thesizing assay after subsequent immunoprecipita- 
tion with specific anti EF-lc~ IgG. The nucleotide 
sequence analysis presented below provides 
definite proof for the identity of the cDNA clone. 
3.2. Nucleotide sequence of the cDNA insert 
The strategy for the sequence analysis of the 
542 bp insert is presented in fig.3a. Some DNA se- 
quences were obtained after isolation of the 
EcoRI-Hind111 pUC8 fragment containing the 
cDNA insert in the PstI sites. Fig.3b shows the en- 
tire nucleotide sequence of the cDNA insert and 
the derived amino acid sequence, which is in agree- 
ment with the partial sequence of the protein chain 
[6]. Both sides of the cDNA show the presence of 
oligo(dC) tails, but no poly(A) tract was found at 
the 3 ‘-end of the coding sequence. 
The cDNA sequence codes for the protein se- 
Fig.2. Hybrid-released translation. Plasmid DNA was 
used to select specific mRNAs. After translation in vitro 
of the selected mRNAs the products were analyzed on a 
12% SDS-polyacrylamide gel: (a) products synthesized 
in vitro (1~1); (b) immunoprecipitation of 5 ~1 assay 
with anti EF-lcu IgG; (1) clone 13 selected mRNA; (2) 
clone 21 selected mRNA; (3) Artemiu poly(A)+ RNA 
(after selection); (4) ‘H-labelled EF-la. The 50 kDa 
band, almost comigrating with EF-la and present in all 
translation assays, is thought to be a product of residual 
mRNA activity in the lysate. 
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Fig.3.(a) Strategy for the sequence analysis of the cloned 
EF-la cDNA, after recloning in pUC8. Positions of 
relevant restriction sites: A, AhI; H, HinfI; H3, HaeIII; 
S, SadAI. 
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PVGRVETGII KPGMIVTFAP 
GACCTGTGGGTCGGGTTGAAACTGGTATCATTAAGCCAGGTATGATAGTCACATTTGCCC 
10 20 30 40 50 60 6 
E 
* 
A N ITTEVKSVEYHHE S L E Q A 
CAGCCAACATAACCACTGAAGTCAAATCCGTCGAAATGCACCACGAATCCCTTG~CAGG 
70 80 90 100 110 I20 
* 
SPGDNVGFNVK NVSVKE L R R 
CATCTCCAGGTGATAAC~:~GGTTTCAATGTCAAAAACGTTTCAGTC~~GAACTTCGTC 
130 150 160 180 
Q E 
* * 
GYVASDSKNN P A R G SQDFFA 
GTGGCTACGTCGCCTCAGATTCAAAGAACAATCCAGCCAGAGGCTCTC~GATTTCTTTG 
190 200 210 220 230 240 
E G E 
* * * 
QVIVLNHPGQI SNGYTPVLD 
CTCAGGTTATTGTCTTGAACCACCCTGGTCAGATCTCAAACGGTTACACTCCTGTCTTGG 
250 260 270 280 290 300 
! 
CHTAHIAC K F A * I K E K C D R R 
ACTGCCACACAGCTCACATTGCTTGCAAGTTTGCTTAGATTAAAGAG~GTGTGACAGAC 
310 320 330 340 350 360 
T G K T T E A E P K FIKSGDAAMI 
GTACTGGCAAAACAACTGAAGCTGAGCCAAAATTTATCAAGTCAGGTGATGCGGCCATGA 
370 300 390 400 410 420 
T LVPSKP LCVEAF SDFPPLG 
TCACTTTGGTACCTTCCAAGCCGTTGTGTGTTGAAGCCTTTTCCGACTTCCCACCTCTTG 
430 440 450 460 470 480 
RFAVRDM RQTVAVGVI K S V N 
GTCGATTTGCTGTCCGTGACATGAGACAAACAGTCGCTGTCGGAGTTATCAAGTCCGTCA 
490 500 510 520 530 540 
AC 
Fig.3.(b) Complete nucleotide sequence of the cloned EF-lcu cDNA and the derived sequence of amino acids. The 
positions where the deduced and the published 161 amino acid sequence differ, are indicated by an asterisk and by the 
residue in the determined sequence of amino acids (see section 4). The lysine residue at position 169 (*) is an e-trimethyl- 
lysine in the protein. The amino acid at the position of the stopcodon (337(!), see the text) has not yet been identified. 
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quence as determined for a C-terminal part of the 
protein [6]. Points of difference are that the Glu 
residue in position 99 corresponds to the serine 
codon TCC and a histidine triplet is found instead 
of a glycine at position 262. In this connection one 
has to keep in mind, that EF-Tu in E. coli is coded 
for by two unlinked genes (tufA and tujB, respec- 
tively) [19], which differ at 13 positions in their 
coding sequences. The corresponding EF-Tu gene 
products are identical except for the C-terminal 
residue. The Gln residues identified by us as CAG 
and GAA codons in the cDNA were given as Glu 
using CNBr peptides where deamination of the 
protein during the cleavage step occurs [a]. 
The presence of a stopcodon at position 337 in 
the coding sequence is not as expected. The most 
likely explanation is a copying error of one of the 
enzymes used for reverse transcription or second 
strand synthesis [20]. Sequence analysis of more 
EF-lcu cDNA clones will clarify this point. The 
EF-la cDNA clone characterized in this report, 
has been used successfully for the determination of 
the size of the mRNA, a rough estimation of the 
number of genes, the isolation of a clone in an 
Artemiu genomic library and the presence of in- 
tervening sequences in this cloned gene [21]. 
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